NEUROPACE, INC. Operating Expenses
NEUROPACE, INC. (NPCE) reported Operating Expenses of $24.05 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-11
- NEUROPACE, INC. operating expenses for the quarter ending 2026-06-30 was $24.05M, a 1.45% decline year-over-year.
- NEUROPACE, INC. operating expenses for the quarter ending 2026-03-31 was $23.62M, a 5.01% increase year-over-year.
- NEUROPACE, INC. operating expenses for the quarter ending 2025-12-31 was $22.34M, a 12.62% increase year-over-year.
- NEUROPACE, INC. operating expenses for the quarter ending 2025-09-30 was $23.77M, a 20.88% increase year-over-year.
- NEUROPACE, INC. operating expenses for fiscal 2025 was $93.56M, a 15.85% increase from fiscal 2024.
- NEUROPACE, INC. operating expenses for fiscal 2024 was $80.76M, a 7.25% increase from fiscal 2023.
- NEUROPACE, INC. operating expenses for fiscal 2023 was $75.30M, a 2.74% increase from fiscal 2022.
- NEUROPACE, INC. operating expenses for fiscal 2022 was $73.29M, a 28.19% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24.05M 10-Q · filed 2026-08-11 | $47.66M 10-Q · filed 2026-08-11 | $70.01M derived: sum of 3 quarters · filed 2026-08-11 | $93.78M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2026-03-31 | $23.62M 10-Q · filed 2026-05-12 | $45.96M derived: sum of 2 quarters · filed 2026-05-12 | $69.73M derived: sum of 3 quarters · filed 2026-05-12 | $94.13M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-12-31 | $22.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $46.11M derived: sum of 2 quarters · filed 2026-03-03 | $70.52M derived: sum of 3 quarters · filed 2026-08-11 | $93.56M 10-K · filed 2026-03-03 | ||
| 2025-09-30 | $23.77M 10-Q · filed 2025-11-04 | $48.17M derived: sum of 2 quarters · filed 2026-08-11 | $71.21M 10-Q · filed 2025-11-04 | $90.50M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-06-30 | $24.40M 10-Q · filed 2026-08-11 | $24.96M 10-Q · filed 2025-08-12 | $46.29M 10-Q · filed 2026-08-11 | $47.45M 10-Q · filed 2025-08-12 | $66.73M derived: sum of 3 quarters · filed 2026-08-11 | $86.39M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $22.49M 10-Q · filed 2026-05-12 | $42.33M derived: sum of 2 quarters · filed 2026-05-12 | $61.99M derived: sum of 3 quarters · filed 2026-05-12 | $82.36M derived: sum of 4 quarters · filed 2026-05-12 | ||
| 2024-12-31 | $19.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $39.50M derived: sum of 2 quarters · filed 2026-03-03 | $59.87M derived: sum of 3 quarters · filed 2026-03-03 | $80.76M 10-K · filed 2026-03-03 | ||
| 2024-09-30 | $19.66M 10-Q · filed 2025-11-04 | $40.03M derived: sum of 2 quarters · filed 2025-11-04 | $60.91M 10-Q · filed 2025-11-04 | $79.51M derived: sum of 4 quarters · filed 2025-11-04 | ||
| 2024-06-30 | $20.36M 10-Q · filed 2025-08-12 | $41.25M 10-Q · filed 2025-08-12 | $59.85M derived: sum of 3 quarters · filed 2025-08-12 | $78.03M derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | $20.89M 10-Q · filed 2025-05-13 | $39.48M derived: sum of 2 quarters · filed 2025-05-13 | $57.67M derived: sum of 3 quarters · filed 2025-05-13 | $77.49M derived: sum of 4 quarters · filed 2025-05-13 | ||
| 2023-12-31 | $18.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $36.78M derived: sum of 2 quarters · filed 2025-03-04 | $56.60M derived: sum of 3 quarters · filed 2025-03-04 | $75.30M 10-K · filed 2025-03-04 | ||
| 2023-09-30 | $18.18M 10-Q · filed 2024-11-12 | $38.01M derived: sum of 2 quarters · filed 2024-11-12 | $56.70M 10-Q · filed 2024-11-12 | $75.36M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | $19.83M 10-Q · filed 2024-08-13 | $38.52M 10-Q · filed 2024-08-13 | $57.18M derived: sum of 3 quarters · filed 2024-08-13 | $75.34M derived: sum of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | $18.69M 10-Q · filed 2024-05-08 | $37.35M derived: sum of 2 quarters · filed 2024-05-08 | $55.52M derived: sum of 3 quarters · filed 2024-05-08 | $73.96M derived: sum of 4 quarters · filed 2024-05-08 | ||
| 2022-12-31 | $18.66M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $36.83M derived: sum of 2 quarters · filed 2024-03-05 | $55.27M derived: sum of 3 quarters · filed 2024-03-05 | $73.29M 10-K · filed 2024-03-05 | ||
| 2022-09-30 | $18.16M 10-Q · filed 2023-11-06 | $36.60M derived: sum of 2 quarters · filed 2023-11-06 | $54.63M 10-Q · filed 2023-11-06 | $71.72M derived: sum of 4 quarters · filed 2023-11-06 | ||
| 2022-06-30 | $18.44M 10-Q · filed 2023-08-08 | $36.46M 10-Q · filed 2023-08-08 | $53.55M derived: sum of 3 quarters · filed 2023-08-08 | $67.30M derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | $18.02M 10-Q · filed 2023-05-04 | $35.11M derived: sum of 2 quarters · filed 2023-05-04 | $48.86M derived: sum of 3 quarters · filed 2023-05-04 | $62.83M derived: sum of 4 quarters · filed 2023-05-04 | ||
| 2021-12-31 | $17.09M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $30.84M derived: sum of 2 quarters · filed 2023-03-02 | $44.80M derived: sum of 3 quarters · filed 2023-03-02 | $57.17M 10-K · filed 2023-03-02 | ||
| 2021-09-30 | $13.75M 10-Q · filed 2022-11-08 | $27.71M derived: sum of 2 quarters · filed 2022-11-08 | $40.08M 10-Q · filed 2022-11-08 | $51.28M derived: sum of 4 quarters · filed 2022-11-08 | ||
| 2021-06-30 | $13.96M 10-Q · filed 2022-08-11 | $26.33M 10-Q · filed 2022-08-11 | $37.53M derived: sum of 3 quarters · filed 2022-08-11 | $48.27M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $12.37M 10-Q · filed 2022-05-12 | $23.57M derived: sum of 2 quarters · filed 2022-05-12 | $34.31M derived: sum of 3 quarters · filed 2022-05-12 | $43.17M derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $11.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $21.94M derived: sum of 2 quarters · filed 2022-03-10 | $30.81M derived: sum of 3 quarters · filed 2022-03-10 | $43.32M 10-K · filed 2022-03-10 | ||
| 2020-09-30 | $10.74M 10-Q · filed 2021-11-10 | $19.61M derived: sum of 2 quarters · filed 2021-11-10 | $32.12M 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | $8.87M 10-Q · filed 2021-08-12 | $21.38M 10-Q · filed 2021-08-12 | ||||
| 2020-03-31 | $12.52M 10-Q · filed 2021-06-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |